VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 118 filers reported holding VANDA PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 0.52 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $189,639 | -81.3% | 43,898 | -71.5% | 0.00% | – |
| Q2 2023 | $1,016,357 | +8.0% | 154,227 | +11.2% | 0.00% | – |
| Q1 2023 | $941,455 | -9.1% | 138,653 | -1.1% | 0.00% | – |
| Q4 2022 | $1,036,210 | -23.1% | 140,218 | +2.8% | 0.00% | -100.0% |
| Q3 2022 | $1,348,000 | -8.4% | 136,382 | +1.1% | 0.00% | 0.0% |
| Q2 2022 | $1,471,000 | -2.7% | 134,874 | +0.9% | 0.00% | – |
| Q1 2022 | $1,512,000 | -28.6% | 133,651 | -1.0% | 0.00% | -100.0% |
| Q4 2021 | $2,118,000 | -5.2% | 134,998 | +3.6% | 0.00% | 0.0% |
| Q3 2021 | $2,234,000 | -12.5% | 130,322 | +9.8% | 0.00% | 0.0% |
| Q2 2021 | $2,554,000 | +10.1% | 118,712 | -23.1% | 0.00% | 0.0% |
| Q1 2021 | $2,320,000 | +16.4% | 154,422 | +1.8% | 0.00% | 0.0% |
| Q4 2020 | $1,993,000 | +35.8% | 151,705 | -0.2% | 0.00% | 0.0% |
| Q3 2020 | $1,468,000 | -14.6% | 151,969 | +1.2% | 0.00% | 0.0% |
| Q2 2020 | $1,718,000 | +16.4% | 150,163 | +5.4% | 0.00% | 0.0% |
| Q1 2020 | $1,476,000 | -34.9% | 142,468 | +3.0% | 0.00% | 0.0% |
| Q4 2019 | $2,269,000 | +33.6% | 138,292 | +8.2% | 0.00% | 0.0% |
| Q3 2019 | $1,698,000 | -3.2% | 127,870 | +2.7% | 0.00% | 0.0% |
| Q2 2019 | $1,754,000 | -23.3% | 124,505 | +0.2% | 0.00% | 0.0% |
| Q1 2019 | $2,287,000 | -21.2% | 124,291 | +11.2% | 0.00% | -50.0% |
| Q4 2018 | $2,902,000 | +13.2% | 111,750 | +0.1% | 0.00% | 0.0% |
| Q3 2018 | $2,563,000 | +1564.3% | 111,631 | +1283.3% | 0.00% | – |
| Q2 2018 | $154,000 | +13.2% | 8,070 | +0.1% | 0.00% | – |
| Q1 2018 | $136,000 | -22.7% | 8,065 | -30.4% | 0.00% | – |
| Q4 2017 | $176,000 | -22.5% | 11,595 | -8.4% | 0.00% | – |
| Q3 2017 | $227,000 | +25.4% | 12,663 | +14.0% | 0.00% | – |
| Q2 2017 | $181,000 | +60.2% | 11,105 | +37.4% | 0.00% | – |
| Q1 2017 | $113,000 | -13.7% | 8,083 | -1.5% | 0.00% | – |
| Q4 2016 | $131,000 | +37.9% | 8,205 | +41.3% | 0.00% | – |
| Q3 2016 | $95,000 | +33.8% | 5,806 | -9.7% | 0.00% | – |
| Q2 2016 | $71,000 | +36.5% | 6,427 | 0.0% | 0.00% | – |
| Q1 2016 | $52,000 | -14.8% | 6,427 | 0.0% | 0.00% | – |
| Q4 2015 | $61,000 | -16.4% | 6,427 | 0.0% | 0.00% | – |
| Q3 2015 | $73,000 | -11.0% | 6,427 | 0.0% | 0.00% | – |
| Q2 2015 | $82,000 | +36.7% | 6,427 | 0.0% | 0.00% | – |
| Q1 2015 | $60,000 | -37.5% | 6,427 | 0.0% | 0.00% | – |
| Q4 2014 | $96,000 | +43.3% | 6,427 | 0.0% | 0.00% | – |
| Q3 2014 | $67,000 | – | 6,427 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 4,658,759 | $121,733,000 | 8.95% |
| Palo Alto Investors LP | 4,155,670 | $108,588,000 | 5.78% |
| Stonepine Capital Management, LLC | 220,848 | $5,771,000 | 5.07% |
| Birchview Capital, LP | 80,000 | $2,090,000 | 1.98% |
| EAM Global Investors LLC | 75,310 | $1,968,000 | 1.08% |
| Atika Capital Management LLC | 130,000 | $3,397,000 | 1.00% |
| EAM Investors, LLC | 110,806 | $2,895,000 | 0.79% |
| UNIVERSITY OF NOTRE DAME DU LAC | 97,521 | $2,548,000 | 0.62% |
| ALGERT GLOBAL LLC | 76,204 | $1,991,000 | 0.56% |
| 361 CAPITAL LLC | 85,885 | $2,244,000 | 0.46% |